BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29237705)

  • 1. Cilia loss sensitizes cells to transformation by activating the mevalonate pathway.
    Deng YZ; Cai Z; Shi S; Jiang H; Shang YR; Ma N; Wang JJ; Guan DX; Chen TW; Rong YF; Qian ZY; Zhang EB; Feng D; Zhou QL; Du YN; Liu DP; Huang XX; Liu LM; Chin E; Li DS; Wang XF; Zhang XL; Xie D
    J Exp Med; 2018 Jan; 215(1):177-195. PubMed ID: 29237705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YEATS4 promotes the tumorigenesis of pancreatic cancer by activating beta-catenin/TCF signaling.
    Jixiang C; Shengchun D; Jianguo Q; Zhengfa M; Xin F; Xuqing W; Jianxin Z; Lei C
    Oncotarget; 2017 Apr; 8(15):25200-25210. PubMed ID: 28445953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDAC2 promotes loss of primary cilia in pancreatic ductal adenocarcinoma.
    Kobayashi T; Nakazono K; Tokuda M; Mashima Y; Dynlacht BD; Itoh H
    EMBO Rep; 2017 Feb; 18(2):334-343. PubMed ID: 28028031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIF11 manipulates SREBP2-dependent mevalonate cross talk to promote tumor progression in pancreatic ductal adenocarcinoma.
    Gu X; Zhu Q; Tian G; Song W; Wang T; Wang A; Chen X; Qin S
    Cancer Med; 2022 Sep; 11(17):3282-3295. PubMed ID: 35619540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas.
    Chen NM; Singh G; Koenig A; Liou GY; Storz P; Zhang JS; Regul L; Nagarajan S; Kühnemuth B; Johnsen SA; Hebrok M; Siveke J; Billadeau DD; Ellenrieder V; Hessmann E
    Gastroenterology; 2015 May; 148(5):1024-1034.e9. PubMed ID: 25623042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma.
    Vaz AP; Deb S; Rachagani S; Dey P; Muniyan S; Lakshmanan I; Karmakar S; Smith L; Johansson S; Lele S; Ouellette M; Ponnusamy MP; Batra SK
    Oncotarget; 2016 Jan; 7(3):3317-31. PubMed ID: 26689992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis of pancreatic cancer stem cells: Functional role of fatty acid synthesis and mevalonate pathways.
    Brandi J; Dando I; Pozza ED; Biondani G; Jenkins R; Elliott V; Park K; Fanelli G; Zolla L; Costello E; Scarpa A; Cecconi D; Palmieri M
    J Proteomics; 2017 Jan; 150():310-322. PubMed ID: 27746256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.
    Aichler M; Seiler C; Tost M; Siveke J; Mazur PK; Da Silva-Buttkus P; Bartsch DK; Langer P; Chiblak S; Dürr A; Höfler H; Klöppel G; Müller-Decker K; Brielmeier M; Esposito I
    J Pathol; 2012 Apr; 226(5):723-34. PubMed ID: 21984419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A human cancer xenograft model utilizing normal pancreatic duct epithelial cells conditionally transformed with defined oncogenes.
    Inagawa Y; Yamada K; Yugawa T; Ohno S; Hiraoka N; Esaki M; Shibata T; Aoki K; Saya H; Kiyono T
    Carcinogenesis; 2014 Aug; 35(8):1840-6. PubMed ID: 24858378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs of the mir-17~92 cluster regulate multiple aspects of pancreatic tumor development and progression.
    Quattrochi B; Gulvady A; Driscoll DR; Sano M; Klimstra DS; Turner CE; Lewis BC
    Oncotarget; 2017 May; 8(22):35902-35918. PubMed ID: 28415794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early requirement of Rac1 in a mouse model of pancreatic cancer.
    Heid I; Lubeseder-Martellato C; Sipos B; Mazur PK; Lesina M; Schmid RM; Siveke JT
    Gastroenterology; 2011 Aug; 141(2):719-30, 730.e1-7. PubMed ID: 21684285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
    Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C
    Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium sensing receptor suppresses human pancreatic tumorigenesis through a novel NCX1/Ca(2+)/β-catenin signaling pathway.
    Tang B; Chow JY; Dong TX; Yang SM; Lu DS; Carethers JM; Dong H
    Cancer Lett; 2016 Jul; 377(1):44-54. PubMed ID: 27108064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of WNT/β-Catenin Signaling Enhances Pancreatic Cancer Development and the Malignant Potential Via Up-regulation of Cyr61.
    Sano M; Driscoll DR; DeJesus-Monge WE; Quattrochi B; Appleman VA; Ou J; Zhu LJ; Yoshida N; Yamazaki S; Takayama T; Sugitani M; Nemoto N; Klimstra DS; Lewis BC
    Neoplasia; 2016 Dec; 18(12):785-794. PubMed ID: 27889647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bmi1 combines with oncogenic KRAS to induce malignant transformation of human pancreatic duct cells in vitro.
    Chen SJ; Chen YT; Zeng LJ; Zhang QB; Lian GD; Li JJ; Yang KG; Huang CM; Li YQ; Chu ZH; Huang KH
    Tumour Biol; 2016 Aug; 37(8):11299-309. PubMed ID: 26951514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer.
    Zhang S; Chung WC; Xu K
    Oncogene; 2016 May; 35(19):2485-95. PubMed ID: 26279302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXC2 is up-regulated in pancreatic ductal adenocarcinoma and promotes the growth and migration of cancer cells.
    Cui L; Dang S; Qu J; Mao Z; Wang X; Zhang J; Chen J
    Tumour Biol; 2016 Jul; 37(7):8579-85. PubMed ID: 26733175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-oxidative transcription factor Nuclear factor E2 related factor-2 (Nrf2) counteracts TGF-β1 mediated growth inhibition of pancreatic ductal epithelial cells -Nrf2 as determinant of pro-tumorigenic functions of TGF-β1.
    Genrich G; Kruppa M; Lenk L; Helm O; Broich A; Freitag-Wolf S; Röcken C; Sipos B; Schäfer H; Sebens S
    BMC Cancer; 2016 Feb; 16():155. PubMed ID: 26915435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of GLI Underlies a Role for BET Bromodomains in Pancreatic Cancer Growth and the Tumor Microenvironment.
    Huang Y; Nahar S; Nakagawa A; Fernandez-Barrena MG; Mertz JA; Bryant BM; Adams CE; Mino-Kenudson M; Von Alt KN; Chang K; Conery AR; Hatton C; Sims RJ; Fernandez-Zapico ME; Wang X; Lillemoe KD; Fernández-Del Castillo C; Warshaw AL; Thayer SP; Liss AS
    Clin Cancer Res; 2016 Aug; 22(16):4259-70. PubMed ID: 27169995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.